Traxion Sab De Cv Ord Shs GRPOF

RE:RE:The TBP policy

[Buster146]

Yes it’s nice to know what’s being done where are we and piece it to the big picture.  I see the end it looks fantastic.  I will be a shareholder until I pass.   As for the stock price we will see I see a big movement sooner and what I mean by big it could be any amount but it will be significant 

LeafRider wrote:

KnowledgeBase wrote: Tetra's formula has been "lets do it, then lets talk about it". From a business standpoint this can be a solid practice. However in the stock world rumours can move things. This is why other companies who have been marketing "what they may do" have seen some pops. This being said when you deliver on deals, even without the hype surrounding them eventually you will reach a point where people take notice. When this happens it will be fast and furious. Since there is no maybe in the scenario, people would be buying on the facts of today not the promise of tomorrow. 

In short more media exposure is always a good thing, but having the proper foundation and products will ultimately be what wins out. I'm sure once TBP can finally take some of their products to market they will begin to focus more on marketing them. 

 

I sure hope they launch their e-commerce site on October 17th. I'll be purchasing Hemp Energy Drink online if it's available. Along with their other products, sure they have partners in which they are developing products, but having their "Tetra Bio-Pharma" skews and sold from their own retail levels will definitley help on revenues. I think what we need to remember is there are some strict rules from Health Canada on "advertising" and "marketing" when it comes to cannabis companies. I think what we'd "like to see" vs. "what they are allowed to do" is the big difference here.

Long investors can appreciate being kept up to date on our progress that is a good thing! Knowing that PPP001 has to wrap up the clinicals and everything else is on the verge of a DIN# approval is huge for us. Collecting royalties and lump sums from Kamada and Azevedos in Israel and Portugal is a great start once DIN# is approved. These two players will be footing the bill for marketing and commercialization efforts in those countries, meanwhile we collect straight revenues. 

Consider that eventually we'll have other partnerships that will continue to do add to our revenues. Eventually when you have PPP001, 002, 005 all hitting the market for drug sales with DIN#'s and insurance coverage you will build towards $100's of millions of revenues at some point. See GW Pharma, stay patient. It's not just endless green all the time. Things do pullback, but the big run is around the corner. 1 Year from today we'll see $3 CDN, without question, clinical trials will matter!